338 related articles for article (PubMed ID: 30665703)
1. Assessing the Pathogenicity, Penetrance, and Expressivity of Putative Disease-Causing Variants in a Population Setting.
Wright CF; West B; Tuke M; Jones SE; Patel K; Laver TW; Beaumont RN; Tyrrell J; Wood AR; Frayling TM; Hattersley AT; Weedon MN
Am J Hum Genet; 2019 Feb; 104(2):275-286. PubMed ID: 30665703
[TBL] [Abstract][Full Text] [Related]
2. Penetrance and expressivity of mitochondrial variants in a large clinically unselected population.
Cannon SJ; Hall T; Hawkes G; Colclough K; Boggan RM; Wright CF; Pickett SJ; Hattersley AT; Weedon MN; Patel KA
Hum Mol Genet; 2024 Feb; 33(5):465-474. PubMed ID: 37988592
[TBL] [Abstract][Full Text] [Related]
3. Statistical evidence for high-penetrance MODY-causing genes in a large population-based cohort.
Billings LK; Shi Z; Resurreccion WK; Wang CH; Wei J; Pollin TI; Udler MS; Xu J
Endocrinol Diabetes Metab; 2022 Nov; 5(6):e372. PubMed ID: 36208030
[TBL] [Abstract][Full Text] [Related]
4. Population-Based Penetrance of Deleterious Clinical Variants.
Forrest IS; Chaudhary K; Vy HMT; Petrazzini BO; Bafna S; Jordan DM; Rocheleau G; Loos RJF; Nadkarni GN; Cho JH; Do R
JAMA; 2022 Jan; 327(4):350-359. PubMed ID: 35076666
[TBL] [Abstract][Full Text] [Related]
5. Frequency and Phenotype Associations of Rare Variants in 5 Monogenic Cerebral Small Vessel Disease Genes in 200,000 UK Biobank Participants.
Ferguson AC; Thrippleton S; Henshall D; Whittaker E; Conway B; MacLeod M; Malik R; Rawlik K; Tenesa A; Sudlow C; Rannikmae K
Neurol Genet; 2022 Oct; 8(5):e200015. PubMed ID: 36035235
[TBL] [Abstract][Full Text] [Related]
6. Rare genetic variants in genes and loci linked to dominant monogenic developmental disorders cause milder related phenotypes in the general population.
Kingdom R; Tuke M; Wood A; Beaumont RN; Frayling TM; Weedon MN; Wright CF
Am J Hum Genet; 2022 Jul; 109(7):1308-1316. PubMed ID: 35700724
[TBL] [Abstract][Full Text] [Related]
7. A spectrum of recessiveness among Mendelian disease variants in UK Biobank.
Barton AR; Hujoel MLA; Mukamel RE; Sherman MA; Loh PR
Am J Hum Genet; 2022 Jul; 109(7):1298-1307. PubMed ID: 35649421
[TBL] [Abstract][Full Text] [Related]
8. Rare variant association analysis in 51,256 type 2 diabetes cases and 370,487 controls informs the spectrum of pathogenicity of monogenic diabetes genes.
Schroeder P; Mandla R; Huerta-Chagoya A; Alkanak A; Nagy D; Szczerbinski L; Madsen JGS; Cole JB; Porneala B; Westerman K; Li JH; Pollin TI; Florez JC; Gloyn AL; Cebola I; Manning A; Leong A; Udler M; Mercader JM
medRxiv; 2023 Sep; ():. PubMed ID: 37808701
[TBL] [Abstract][Full Text] [Related]
9. Determinants of penetrance and variable expressivity in monogenic metabolic conditions across 77,184 exomes.
Goodrich JK; Singer-Berk M; Son R; Sveden A; Wood J; England E; Cole JB; Weisburd B; Watts N; Caulkins L; Dornbos P; Koesterer R; Zappala Z; Zhang H; Maloney KA; Dahl A; Aguilar-Salinas CA; Atzmon G; Barajas-Olmos F; Barzilai N; Blangero J; Boerwinkle E; Bonnycastle LL; Bottinger E; Bowden DW; Centeno-Cruz F; Chambers JC; Chami N; Chan E; Chan J; Cheng CY; Cho YS; Contreras-Cubas C; Córdova E; Correa A; DeFronzo RA; Duggirala R; Dupuis J; Garay-Sevilla ME; García-Ortiz H; Gieger C; Glaser B; González-Villalpando C; Gonzalez ME; Grarup N; Groop L; Gross M; Haiman C; Han S; Hanis CL; Hansen T; Heard-Costa NL; Henderson BE; Hernandez JMM; Hwang MY; Islas-Andrade S; Jørgensen ME; Kang HM; Kim BJ; Kim YJ; Koistinen HA; Kooner JS; Kuusisto J; Kwak SH; Laakso M; Lange L; Lee JY; Lee J; Lehman DM; Linneberg A; Liu J; Loos RJF; Lyssenko V; Ma RCW; Martínez-Hernández A; Meigs JB; Meitinger T; Mendoza-Caamal E; Mohlke KL; Morris AD; Morrison AC; Ng MCY; Nilsson PM; O'Donnell CJ; Orozco L; Palmer CNA; Park KS; Post WS; Pedersen O; Preuss M; Psaty BM; Reiner AP; Revilla-Monsalve C; Rich SS; Rotter JI; Saleheen D; Schurmann C; Sim X; Sladek R; Small KS; So WY; Spector TD; Strauch K; Strom TM; Tai ES; Tam CHT; Teo YY; Thameem F; Tomlinson B; Tracy RP; Tuomi T; Tuomilehto J; Tusié-Luna T; van Dam RM; Vasan RS; Wilson JG; Witte DR; Wong TY; ; Burtt NP; Zaitlen N; McCarthy MI; Boehnke M; Pollin TI; Flannick J; Mercader JM; O'Donnell-Luria A; Baxter S; Florez JC; MacArthur DG; Udler MS
Nat Commun; 2021 Jun; 12(1):3505. PubMed ID: 34108472
[TBL] [Abstract][Full Text] [Related]
10. Clustering of predicted loss-of-function variants in genes linked with monogenic disease can explain incomplete penetrance.
Beaumont RN; Hawkes G; Gunning AC; Wright CF
Genome Med; 2024 Apr; 16(1):64. PubMed ID: 38671509
[TBL] [Abstract][Full Text] [Related]
11. Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants.
Shah RA; Asatryan B; Sharaf Dabbagh G; Aung N; Khanji MY; Lopes LR; van Duijvenboden S; Holmes A; Muser D; Landstrom AP; Lee AM; Arora P; Semsarian C; Somers VK; Owens AT; Munroe PB; Petersen SE; Chahal CAA;
Circulation; 2022 Jul; 146(2):110-124. PubMed ID: 35708014
[TBL] [Abstract][Full Text] [Related]
12. ERCC4 variants identified in a cohort of patients with segmental progeroid syndromes.
Mori T; Yousefzadeh MJ; Faridounnia M; Chong JX; Hisama FM; Hudgins L; Mercado G; Wade EA; Barghouthy AS; Lee L; Martin GM; Nickerson DA; Bamshad MJ; ; Niedernhofer LJ; Oshima J
Hum Mutat; 2018 Feb; 39(2):255-265. PubMed ID: 29105242
[TBL] [Abstract][Full Text] [Related]
13. Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk.
Di Lucca J; Guedj M; Lacapère JJ; Fargnoli MC; Bourillon A; Dieudé P; Dupin N; Wolkenstein P; Aegerter P; Saiag P; Descamps V; Lebbe C; Basset-Seguin N; Peris K; Grandchamp B; Soufir N
Eur J Cancer; 2009 Dec; 45(18):3228-36. PubMed ID: 19477635
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance.
Patel KA; Kettunen J; Laakso M; Stančáková A; Laver TW; Colclough K; Johnson MB; Abramowicz M; Groop L; Miettinen PJ; Shepherd MH; Flanagan SE; Ellard S; Inagaki N; Hattersley AT; Tuomi T; Cnop M; Weedon MN
Nat Commun; 2017 Oct; 8(1):888. PubMed ID: 29026101
[TBL] [Abstract][Full Text] [Related]
15. The Genetic Spectrum of Maturity-Onset Diabetes of the Young (MODY) in Qatar, a Population-Based Study.
Elashi AA; Toor SM; Diboun I; Al-Sarraj Y; Taheri S; Suhre K; Abou-Samra AB; Albagha OME
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613572
[TBL] [Abstract][Full Text] [Related]
16. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the promoter regions of disease-causing genes in maturity-onset diabetes of the young patients.
Komazec J; Ristivojevic B; Zukic B; Zdravkovic V; Karan-Djurasevic T; Pavlovic S; Ugrin M
Mol Biol Rep; 2020 Sep; 47(9):6759-6768. PubMed ID: 32860162
[TBL] [Abstract][Full Text] [Related]
18. Identification of candidate gene variants of monogenic diabetes using targeted panel sequencing in early onset diabetes patients.
Lee DH; Kwak SH; Park HS; Ku EJ; Jeon HJ; Oh TK
BMJ Open Diabetes Res Care; 2021 Jun; 9(1):. PubMed ID: 34135026
[TBL] [Abstract][Full Text] [Related]
19. Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts.
Kingdom R; Wright CF
Front Genet; 2022; 13():920390. PubMed ID: 35983412
[TBL] [Abstract][Full Text] [Related]
20. Genetic modifiers of rare variants in monogenic developmental disorder loci.
Kingdom R; Beaumont RN; Wood AR; Weedon MN; Wright CF
Nat Genet; 2024 May; 56(5):861-868. PubMed ID: 38637616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
